Summary
Fyteko's Nurspray is a biostimulant that makes crops resilient to climate stress. Nurspray activates a plant's tolerance mechanism to drought, heat and salinity, boosting recovery and crop yield. It is non-toxic and compatible with agricultural methods. Field trials have shown yield increases of 12% to 53% over a broad range of crops and locations.
Problem: Heat, drought and salinity are undermining global agricultural output by 50%, worth $100B p.a. Current agrochemicals are insufficient: there is no abiotic stress treatment product.
Solution: Nurspray is the world’s first single-molecule biostimulant with a scientifically proven effect. It competes with other biostimulants which are mix/extracts/microorganisms with limited effect.
Timing: The EU’s revised Directive on Fertilising Products (2019) will allow biostimulants to obtain CE marking in 2022.
Progress: Fyteko has invented and patented Nurspray, produced demonstration batches at scale, proven effectiveness in 170+ tests, and won numerous awards. Trial contracts to treat fields in Latin American and Africa are already signed.
Sales: End-users are farmers, reached through distributors, agrochemical partners and seed companies.
Market: Agrochemicals are worth €5B annually. Biostimulants will disrupt this, as farmers are seeking non-chemical solutions for crop stress management.
Project: Fyteko will improve its formulations; upscale its production process; conduct field trials in eight EU countries (data generation); secure CE Marking; and prepare for European market launch in 2022-2023.
Problem: Heat, drought and salinity are undermining global agricultural output by 50%, worth $100B p.a. Current agrochemicals are insufficient: there is no abiotic stress treatment product.
Solution: Nurspray is the world’s first single-molecule biostimulant with a scientifically proven effect. It competes with other biostimulants which are mix/extracts/microorganisms with limited effect.
Timing: The EU’s revised Directive on Fertilising Products (2019) will allow biostimulants to obtain CE marking in 2022.
Progress: Fyteko has invented and patented Nurspray, produced demonstration batches at scale, proven effectiveness in 170+ tests, and won numerous awards. Trial contracts to treat fields in Latin American and Africa are already signed.
Sales: End-users are farmers, reached through distributors, agrochemical partners and seed companies.
Market: Agrochemicals are worth €5B annually. Biostimulants will disrupt this, as farmers are seeking non-chemical solutions for crop stress management.
Project: Fyteko will improve its formulations; upscale its production process; conduct field trials in eight EU countries (data generation); secure CE Marking; and prepare for European market launch in 2022-2023.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/953636 |
| Start date: | 01-05-2020 |
| End date: | 31-12-2022 |
| Total budget - Public funding: | 2 761 812,00 Euro - 1 933 268,00 Euro |
Cordis data
Original description
Fyteko's Nurspray is a biostimulant that makes crops resilient to climate stress. Nurspray activates a plant's tolerance mechanism to drought, heat and salinity, boosting recovery and crop yield. It is non-toxic and compatible with agricultural methods. Field trials have shown yield increases of 12% to 53% over a broad range of crops and locations.Problem: Heat, drought and salinity are undermining global agricultural output by 50%, worth $100B p.a. Current agrochemicals are insufficient: there is no abiotic stress treatment product.
Solution: Nurspray is the world’s first single-molecule biostimulant with a scientifically proven effect. It competes with other biostimulants which are mix/extracts/microorganisms with limited effect.
Timing: The EU’s revised Directive on Fertilising Products (2019) will allow biostimulants to obtain CE marking in 2022.
Progress: Fyteko has invented and patented Nurspray, produced demonstration batches at scale, proven effectiveness in 170+ tests, and won numerous awards. Trial contracts to treat fields in Latin American and Africa are already signed.
Sales: End-users are farmers, reached through distributors, agrochemical partners and seed companies.
Market: Agrochemicals are worth €5B annually. Biostimulants will disrupt this, as farmers are seeking non-chemical solutions for crop stress management.
Project: Fyteko will improve its formulations; upscale its production process; conduct field trials in eight EU countries (data generation); secure CE Marking; and prepare for European market launch in 2022-2023.
Status
CLOSEDCall topic
EIC-SMEInst-2018-2020Update Date
27-10-2022
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
